EVOLVA BIOTECH A/S: Financial statements 2017
CVR: 25532538
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
EVOLVA BIOTECH A/S (CVR 25532538) has filed annual accounts for 2017. In 2017, the company reported revenue of DKK 69,884,999 and a net result of DKK -724,539 compared with DKK -619,532 the year before. That is an increase of 16.7% compared with the year before. The profit margin was -1%. Equity in the 2017 report amounted to DKK 6,521,019. The solvency ratio was 31%. The company had 57 employees in the financial year.
- Revenue
- DKK 69,884,999
- Gross Profit
- DKK 49,857,024
- Profit/Loss
- DKK -724,539
- Equity
- DKK 6,521,019
- Total Assets
- DKK 21,048,984
- Employees
- 57
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | 69.9 mio. | 49.9 mio. | -725 t. | 6.5 mio. | 57 |
| 2016 | 59.9 mio. | 41.9 mio. | -620 t. | 7.2 mio. | 56 |
| 2015 | 47.7 mio. | - | -1.1 mio. | 7.9 mio. | - |
| 2014 | 39.4 mio. | 28.4 mio. | 1.8 mio. | 8.9 mio. | - |
| 2013 | 27 mio. | 18.9 mio. | -1.2 mio. | 7.1 mio. | - |
Official annual report
Keep an eye on EVOLVA BIOTECH A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
As of December 31, 2017, Nic Bürgin has joined the board of directors of EVOLVA BIOTECH A/S.
As of December 31, 2017, Alessandro Mauro Del Fabro has joined the board of directors of EVOLVA BIOTECH A/S.
As of December 31, 2017, Bo Danner Henriksen has left the board of directors of EVOLVA BIOTECH A/S.
As of December 31, 2017, Jørgen Hansen has left the board of directors of EVOLVA BIOTECH A/S.
As of December 31, 2017, Alessandro Mauro Del Fabro is registered as director of EVOLVA BIOTECH A/S.
As of December 31, 2017, Jørgen Hansen has stepped down as director of EVOLVA BIOTECH A/S.
EVOLVA BIOTECH A/S has published its annual report for 2016. Revenue came to DKK 59,907,653, and the net result was DKK -619,532.
As of January 2, 2017, Oliver Patrick Walker is registered as chairman of EVOLVA BIOTECH A/S.
As of January 2, 2017, Jakob Dynnes Hansen has stepped down as chairman of EVOLVA BIOTECH A/S.
About EVOLVA BIOTECH A/S
EVOLVA BIOTECH A/S was a Danish company of the type Aktieselskab based in København Ø, founded in 2000. The company has been dissolved on 17 June 2022. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company was previously named ARPIDA A/S and COMBIO A/S. The company has 2 employees (2018). In 2020, the company reported a gross profit of DKK -116,208 and a net result of DKK -196,806 compared with DKK -187,015 the year before. Equity in the 2020 report amounted to DKK 6,378,584.